← Feed

u/JoacoFerna24

2 theses · first seen Oct 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ASRTr/pennystocksDDbullish
u/JoacoFerna24 · 2063d ago1 prior · awaiting results
Long 5,000 shares of ASRT

$ASRT (Assertio Therapeutics) why I invested in them and why I´m bullish. 250% upside according to analysts. TOP 1 most mentioned stock the past 2 days here.

Assertio Therapeutics has a robust portfolio of FDA-approved neurology, inflammation, and pain medications and proprietary Acuform drug delivery technology with partnership opportunities. The company has recovered from prior bankruptcy risk and achieved cost reductions and synergies through its Zyla merger, positioning it for 250% upside according to analyst targets.

original post →
$ATOSr/pennystocksDDbullish
u/JoacoFerna24 · 2064d ago1 prior · awaiting results
Long 22,500 shares of ATOS

$ATOS (Atossa Therapeutics) huge upside potential IMO & why I am 100% bullish

Atossa Therapeutics is developing three promising pipeline products: AT-301 (COVID-19 nasal spray completing Phase 1), AT-H201 (COVID-19 therapeutic with potential for faster development than vaccines), and oral endoxifen (addressing metabolic gaps in the most-prescribed breast cancer SERM). The author holds 22,500 shares and sees multiple near-term catalysts from FDA interactions and clinical progression.

At post $43.65Now $2.33-94.7% since postedas of Nov 3, 4:45 PM ET
1d+10.7%
3d0.0%
1w-0.3%
1m-30.6%
3m+108.6%
6m+28.9%
1y-56.0%
original post →

End of results.